WAM
LIMNW

Wolverine Asset Management’s Liminatus Pharma Warrants LIMNW Stock Holding History

Wolverine Asset Management’s Portfolio LIMNW Stock Details LIMNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05K Sell
13,976
-25,397
-65% -$1.75K ﹤0.01% 1580
2026
Q1 		$1.57K Sell
39,373
-23,422
-37% -$1.5K ﹤0.01% 1575
2025
Q4 		$2.2K Sell
62,795
-68
-0.1% -$7 ﹤0.01% 1534
2025
Q3 		$9.3K Sell
62,863
-40,124
-39% -$7.83K ﹤0.01% 1376
2025
Q2 		$24.7K Buy
+102,987
New +$20.2K ﹤0.01% 1291

Other funds holding LIMNW

AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

Wolverine Asset Management's LIMNW Position: Q2 2026 in Review

Wolverine Asset Management reduced its Liminatus Pharma Warrants (LIMNW) stake by 65% in Q2 2026, selling an estimated $1.75K and leaving 13,976 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1580.

Wolverine Asset Management first reported a position in LIMNW in Q2 2025 and has held it in 5 quarters since. The position peaked at $24.7K in Q2 2025. 22 funds tracked by Wall St. Rank hold LIMNW as of Q2 2026.

  • Wolverine Asset Management held 13,976 shares of Liminatus Pharma Warrants worth $1.05K as of Q2 2026.
  • Wolverine Asset Management sold 25,397 Liminatus Pharma Warrants shares in Q2 2026, an estimated $1.75K.
  • Liminatus Pharma Warrants made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #1580 holding.
  • Wolverine Asset Management first reported a position in Liminatus Pharma Warrants in Q2 2025 and has held it in 5 quarters since.
  • Wolverine Asset Management's Liminatus Pharma Warrants position peaked at $24.7K in Q2 2025.
  • 22 funds tracked by Wall St. Rank held Liminatus Pharma Warrants as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.